4//SEC Filing
Xu Jiandong 4
Accession 0001213900-25-014306
CIK 0001844417other
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 4:30 PM ET
Size
9.0 KB
Accession
0001213900-25-014306
Insider Transaction Report
Form 4
Xu Jiandong
Chief Financial Officer
Transactions
- Award
Nonstatutory Share Option
2024-10-30+509,204→ 509,203 totalExercise: $0.81From: 2024-10-31Exp: 2034-10-29→ Common Stock (509,204 underlying) - Award
Incentive Share Option
2024-10-30+490,796→ 490,796 totalExercise: $0.81From: 2024-10-31Exp: 2034-10-29→ Common Stock (490,796 underlying)
Footnotes (4)
- [F1]On October 30, 2024, the Board of Directors (the "Board") of Estrella Immunopharma, Inc. (the "Company"), awarded Mr. Jiangdong "Peter" Xu an incentive share option grant of 490,796 shares.
- [F2]The incentive share options will vest on a schedule, with twenty-five percent (25%) of the award being immediately exercisable on the date of the grant, with the remaining seventy-five percent (75%) vesting in equal monthly installments over the subsequent thirty-six (36) months. Each subsequent monthly vesting will represent a total of 1/48 of the total award, with 1/48th of the total number of shares subject to the option vesting on each monthly anniversary of October 30, 2024.
- [F3]On October 31, 2024, the Board of the Company awarded Mr. Xu a nonstatutory shares option grant of 509,204 shares.
- [F4]The nonstatutory share options will vest on a schedule, with twenty-five percent (25%) of the award being immediately exercisable on the date of the grant, with the remaining seventy-five percent (75%) vesting in equal monthly installments over the subsequent thirty-six (36) months, with 1/48th of the total number of shares subject to the option vesting on each monthly anniversary of October 30, 2024.
Documents
Issuer
Estrella Immunopharma, Inc.
CIK 0001844417
Entity typeother
Related Parties
1- filerCIK 0001920399
Filing Metadata
- Form type
- 4
- Filed
- Feb 13, 7:00 PM ET
- Accepted
- Feb 14, 4:30 PM ET
- Size
- 9.0 KB